These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2998645

  • 1. Kinetic studies on neurotoxin-binding inhibitory antibodies in myasthenia gravis.
    Ito A, Furukawa S, Satoyoshi E, Sakurai H.
    Clin Chim Acta; 1985 Nov 15; 152(3):315-23. PubMed ID: 2998645
    [Abstract] [Full Text] [Related]

  • 2. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B, Harrison R, Lunt GG, Morris H, Savage-Marengo T, Stephenson FA.
    Ann Clin Biochem; 1981 May 15; 18(Pt 3):146-52. PubMed ID: 7283364
    [Abstract] [Full Text] [Related]

  • 3. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
    Fulpius BW, Miskin R, Reich E.
    Proc Natl Acad Sci U S A; 1980 Jul 15; 77(7):4326-30. PubMed ID: 6933485
    [Abstract] [Full Text] [Related]

  • 4. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B, Morel E, Bach JF.
    C R Acad Sci III; 1984 Jul 15; 298(16):449-56. PubMed ID: 6428718
    [Abstract] [Full Text] [Related]

  • 5. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T, Simpson JA.
    J Clin Lab Immunol; 1982 Nov 15; 9(2):113-7. PubMed ID: 7154056
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B, Morel E, Bach JF.
    J Neuroimmunol; 1986 Jul 15; 12(1):65-74. PubMed ID: 3711314
    [Abstract] [Full Text] [Related]

  • 7. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M.
    Clin Chem; 1993 Oct 15; 39(10):2053-7. PubMed ID: 8403390
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T, Raftery MA.
    J Supramol Struct; 1980 Oct 15; 14(3):267-79. PubMed ID: 6971372
    [Abstract] [Full Text] [Related]

  • 9. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
    Almon RR, Andrew CG, Appel SH.
    Science; 1974 Oct 04; 186(4158):55-7. PubMed ID: 4421998
    [Abstract] [Full Text] [Related]

  • 10. The effects of a myasthenic serum on the acetylcholine receptors of C2 myotubes. II. Functional inactivation of the receptor.
    Maricq AV, Gu Y, Hestrin S, Hall Z.
    J Neurosci; 1985 Jul 04; 5(7):1917-24. PubMed ID: 2410577
    [Abstract] [Full Text] [Related]

  • 11. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR, Appel SH.
    Biochim Biophys Acta; 1975 May 30; 393(1):66-77. PubMed ID: 1138925
    [Abstract] [Full Text] [Related]

  • 12. A practical enzyme immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis.
    Furukawa S, Akazawa S, Furukawa Y, Kamo I, Satoyoshi E, Hayashi K.
    J Neuroimmunol; 1984 May 30; 6(6):397-409. PubMed ID: 6384263
    [Abstract] [Full Text] [Related]

  • 13. Anti-acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cells.
    Pachner AR.
    Neurology; 1989 Aug 30; 39(8):1057-61. PubMed ID: 2761699
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B, Bach JF, Morel E.
    Clin Exp Immunol; 1987 Apr 30; 68(1):130-7. PubMed ID: 3652512
    [Abstract] [Full Text] [Related]

  • 15. [Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases].
    Toyka KV, Heininger K.
    Dtsch Med Wochenschr; 1986 Sep 19; 111(38):1435-9. PubMed ID: 3757800
    [Abstract] [Full Text] [Related]

  • 16. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
    Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A.
    Neurology; 1983 Oct 19; 33(10):1316-21. PubMed ID: 6684226
    [Abstract] [Full Text] [Related]

  • 17. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K, Goto I, Kuroiwa Y, Onoue K, Ito Y.
    Neurology; 1980 May 19; 30(5):543-6. PubMed ID: 7189261
    [Abstract] [Full Text] [Related]

  • 18. Measurement of human skeletal muscle acetylcholine receptor antibodies using monkey receptors.
    Mickle DA, Wong PY, Humphrey JG, Griffith K, Mee AV.
    Clin Biochem; 1983 Jun 19; 16(3):163-6. PubMed ID: 6851078
    [Abstract] [Full Text] [Related]

  • 19. Is there acetylcholine receptor in human thymus?
    Nicholson GA, Appel SH.
    J Neurol Sci; 1977 Oct 19; 34(1):101-8. PubMed ID: 915531
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T, Beyth Y, Abramsky O.
    Proc Natl Acad Sci U S A; 1980 Jun 19; 77(6):3635-9. PubMed ID: 6158053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.